Histamine H1 receptor

From Proteopedia

(Difference between revisions)

Revision as of 03:40, 9 April 2023

Histamine H1 Receptor

Histamine H1 receptor with an antagonist doxepin, lipid and phosphate (PDB code 3rze)

Drag the structure with the mouse to rotate

Allergy symptoms are mostly caused by the release of histamine in response to allergens. The binding of histamine to the extracellular portion of the H1 receptor triggers a structural change of the transmembrane portion, leading to a change in the C terminal area. This c terminal region interacts with G proteins, leading to the activation of the Gq signalling pathway, which triggers allergy symptoms like itchy eyes and runny noses. Many allergy drugs are anti-histamines, in that they bind to the histamine receptor but do not cause the conformational change that leads to a response. See also Receptor.

Structural highlights

The structure of the H1 histamine receptor bound to an antihistamine, doxepin was published in 2011 ^[1]. A view colors the N terminus blue and the C terminus red, with the intervening segments paralleling the rainbow (blue, green, yellow, orange, red). This image is oriented with the transmembrane section at the top and the cytosolic portion below. The are shown in grey, while hydrophilic amino acids are shown in purple.

was originally made as a tricyclic antidepressant, but it also is a potent antihistamine ^[2] binds among the transmembrane alpha helices. Binding is stabilized by a number of . Like many G protein coupled receptors, the bottom of the binding pocket contains a conserved residue. Interestingly, second generation antihistamines take advantage of an anion binding site formed by ; in this structure, they interact with a phosphate.

Like other G protein-coupled receptors, the Histamine H1 Receptor contains a (aspartate (D), arginine (R), tyrosine (Y)) motif in the seven helix transmembrane surface near the cytosolic face. In some G protein receptors, an "ionic lock" interaction between the asparate and arginine in this motif stabilizes the inactive state^[3]; however, in the Histamine H1 receptor, Arginine 125 forms a hydrogen bond with , which stabilizes the inactive state.

3D structures of histamine H1 receptor

Updated on 09-April-2023

3rze - hHHR + doxepin + lipid + phosphate - human
7dfl - hHHR + guanine nucleotide-binding protein + scFv + histamine - Cryo EM

References

↑ Shimamura T, Shiroishi M, Weyand S, Tsujimoto H, Winter G, Katritch V, Abagyan R, Cherezov V, Liu W, Han GW, Kobayashi T, Stevens RC, Iwata S. Structure of the human histamine H1 receptor complex with doxepin. Nature. 2011 Jun 22;475(7354):65-70. doi: 10.1038/nature10236. PMID:21697825 doi:10.1038/nature10236
↑ Richelson E. Tricyclic antidepressants and histamine H1 receptors. Mayo Clin Proc. 1979 Oct;54(10):669-74. PMID:39202
↑ Rovati GE, Capra V, Neubig RR. The highly conserved DRY motif of class A G protein-coupled receptors: beyond the ground state. Mol Pharmacol. 2007 Apr;71(4):959-64. doi: 10.1124/mol.106.029470. Epub 2006 Dec , 27. PMID:17192495 doi:http://dx.doi.org/10.1124/mol.106.029470

Proteopedia Page Contributors and Editors (what is this?)

Ann Taylor, Michal Harel, Alexander Berchansky

Retrieved from "http://52.214.119.220/wiki/index.php/Histamine_H1_receptor"

@@ Line 1: / Line 1: @@
 ==Histamine H1 Receptor==
-<StructureSection load='3RZE' size='340' side='right' caption='Histamine H1 receptor with an antagonist doxepin, lipid and phosphate (PDB code [[3rze]])' scene='<scene name='78/784820/2ndary_structure_color/1'></scene>'>
+<StructureSection load='3RZE' size='340' side='right' caption='Histamine H1 receptor with an antagonist doxepin, lipid and phosphate (PDB code [[3rze]])' scene='78/784820/2ndary_structure_color/1'>
 Allergy symptoms are mostly caused by the release of histamine in response to allergens.  The binding of histamine to the extracellular portion of the '''H1 receptor''' triggers a structural change of the transmembrane portion, leading to a change in the C terminal area.  This c terminal region interacts with G proteins, leading to the activation of the Gq signalling pathway, which triggers allergy symptoms like itchy eyes and runny noses. Many allergy drugs are anti-histamines, in that they bind to the histamine receptor but do not cause the conformational change that leads to a response. See also [[Receptor]].

Histamine H1 receptor

From Proteopedia

Revision as of 03:40, 9 April 2023